At a glance
ClinicalIndex Comparison RecordN/ACompleted· 246 enrolled
Drug / intervention
Pioglitazonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Actos Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>
In Brief
An observational study evaluating Pioglitazone for Type 2 Diabetes Mellitus. Completed, enrolled 246 participants.
Detailed Summary
The purpose of this survey is to evaluate the effects on glycemic control and to evaluate the safety of long-term use of pioglitazone tablets (Actos Tablets) in type 2 diabetic patients with inadequate glycemic control and a prior history of cerebral infarction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionJun 2011
First PostedJul 2014
TodayJul 2026
First PostedJul 4, 2014
Enrollment StartJan 26, 2009
Primary CompletionJun 30, 2011
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.0 years ago
Interventions
Pioglitazonedrug
Pioglitazone tablets